<?xml version="1.0" encoding="utf-8"?><api:response xmlns:api="http://www.symplectic.co.uk/publications/api"><api:version uri="https://mypublications.shef.ac.uk/" elements-version="6.15.0.3976" schema-version="6.13" product-name="myPublications"/><api:request href="https://mypublications.shef.ac.uk:8091/secure-api/v6.13/publications/848"/><api:result><api:object category="publication" id="848" last-affected-when="2024-03-17T09:11:19.39+00:00" last-modified-when="2024-03-17T09:11:19.39+00:00" href="https://mypublications.shef.ac.uk:8091/secure-api/v6.13/publications/848" created-when="2010-05-17T13:46:30.74+01:00" type-id="5" type-display-name="Journal article" type="journal-article"><api:privacy-level>Public</api:privacy-level><api:privacy-level-locked>false</api:privacy-level-locked><api:ever-approved>true</api:ever-approved><api:reporting-date-1>1999-01-01</api:reporting-date-1><api:allow-type-switching>true</api:allow-type-switching><api:records><api:record format="native" id="1351718" source-id="13" source-name="crossref" source-display-name="Crossref" id-at-source="10.1016/S0163-4453(99)90043-9" last-modified-when="2022-09-12T00:34:37.92+01:00"><api:native><api:field name="authors" type="person-list" display-name="Authors"><api:people><api:person><api:links><api:link type="elements/user" id="1878" href="https://mypublications.shef.ac.uk:8091/secure-api/v6.13/users/1878"/></api:links><api:last-name>Read</api:last-name><api:initials>RC</api:initials><api:first-names>Robert C</api:first-names><api:separate-first-names><api:first-name>Robert</api:first-name><api:first-name>C</api:first-name></api:separate-first-names></api:person></api:people></api:field><api:field name="doi" type="text" display-name="DOI"><api:text>10.1016/s0163-4453(99)90043-9</api:text><api:links><api:link type="doi" href="http://doi.org/10.1016/s0163-4453(99)90043-9"/><api:link type="altmetric" href="http://www.altmetric.com/details.php?doi=10.1016/s0163-4453(99)90043-9"/></api:links></api:field><api:field name="issn" type="text" display-name="ISSN"><api:text>0163-4453</api:text><api:links><api:link type="elements/journal" href="https://mypublications.shef.ac.uk:8091/secure-api/v6.13/journals/974105"/></api:links></api:field><api:field name="issue" type="text" display-name="Issue"><api:text>3</api:text></api:field><api:field name="journal" type="text" display-name="Journal"><api:text>Journal of Infection</api:text></api:field><api:field name="language" type="text" display-name="Language"><api:text>en</api:text></api:field><api:field name="pagination" type="pagination" display-name="Pagination"><api:pagination><api:begin-page>171</api:begin-page><api:end-page>178</api:end-page></api:pagination></api:field><api:field name="publication-date" type="date" display-name="Publication date"><api:date><api:month>11</api:month><api:year>1999</api:year></api:date></api:field><api:field name="publication-status" type="text" display-name="Status"><api:text>Published</api:text></api:field><api:field name="publisher" type="text" display-name="Publisher"><api:text>Elsevier BV</api:text></api:field><api:field name="publisher-url" type="text" display-name="Link 2"><api:text>http://dx.doi.org/10.1016/s0163-4453(99)90043-9</api:text></api:field><api:field name="record-created-at-source-date" type="date" display-name="Record created at source"><api:date><api:day>31</api:day><api:month>3</api:month><api:year>2020</api:year></api:date></api:field><api:field name="title" type="text" display-name="Title"><api:text>Evidence-based medicine: Empiric antibiotic therapy in community-acquired pneumonia</api:text></api:field><api:field name="volume" type="text" display-name="Volume"><api:text>39</api:text></api:field></api:native></api:record><api:record format="native" id="95103" source-id="7" source-name="scopus" source-display-name="Scopus" id-at-source="2-s2.0-0033383958" last-modified-when="2023-11-22T06:26:14.697+00:00"><api:citation-count>13</api:citation-count><api:native><api:field name="abstract" type="text" display-name="Abstract"><api:text>A number of national society guidelines exist for empiric management of community-acquired pneumonia but these are, to a large extent, not evidence-based, but based on clinical experience, in vitro data, pragmatism and common sense. Many randomized controlled trials of antibiotic therapy in community-acquired pneumonia have been conducted, but most of these have been powered to demonstrate equivalent efficacy of new treatments in comparison with conventional antimicrobial therapy. Development of new antibiotics has been driven by the emergence of penicillin-resistant Streptococcus pneumoniae, but so far there is no hard evidence that Î²-lactam therapy fails in community-acquired pneumonia, at least with the higher doses of penicillins that are commonly used in hospital practice. Nonetheless, newer antibiotics have been deployed including macrolides and quinolones, and have demonstrated equivalent (and in some cases, marginally improved) efficacy to older antibiotic treatments in randomized control trials. A number of studies have shown that it is possible to stratify patients according to severity of illness, to in-patient or out-patient management protocols. These have been validated and refined. (C) 1999 The British Infection Society.</api:text></api:field><api:field name="authors" type="person-list" display-name="Authors"><api:people><api:person><api:links><api:link type="elements/user" id="1878" href="https://mypublications.shef.ac.uk:8091/secure-api/v6.13/users/1878"/></api:links><api:last-name>Read</api:last-name><api:initials>RC</api:initials><api:first-names>RC</api:first-names><api:separate-first-names><api:first-name>R</api:first-name><api:first-name>C</api:first-name></api:separate-first-names><api:addresses><api:address iso-country-code="GB"><api:line type="organisation">The Sheffield Medical School</api:line><api:line type="city">Sheffield</api:line><api:line type="country">United Kingdom</api:line></api:address></api:addresses><api:identifiers><api:identifier scheme="scopus-author-id">55978904400</api:identifier></api:identifiers></api:person></api:people></api:field><api:field name="doi" type="text" display-name="DOI"><api:text>10.1016/S0163-4453(99)90043-9</api:text><api:links><api:link type="doi" href="http://doi.org/10.1016/S0163-4453(99)90043-9"/><api:link type="altmetric" href="http://www.altmetric.com/details.php?doi=10.1016/S0163-4453(99)90043-9"/></api:links></api:field><api:field name="external-identifiers" type="identifier-list" display-name="External identifiers"><api:identifiers><api:identifier scheme="pubmed">10714789</api:identifier></api:identifiers></api:field><api:field name="issn" type="text" display-name="ISSN"><api:text>0163-4453</api:text><api:links><api:link type="elements/journal" href="https://mypublications.shef.ac.uk:8091/secure-api/v6.13/journals/974105"/></api:links></api:field><api:field name="issue" type="text" display-name="Issue"><api:text>3</api:text></api:field><api:field name="journal" type="text" display-name="Journal"><api:text>Journal of Infection</api:text></api:field><api:field name="pagination" type="pagination" display-name="Pagination"><api:pagination><api:begin-page>171</api:begin-page><api:end-page>178</api:end-page></api:pagination></api:field><api:field name="publication-date" type="date" display-name="Publication date"><api:date><api:day>1</api:day><api:month>1</api:month><api:year>1999</api:year></api:date></api:field><api:field name="publication-status" type="text" display-name="Status"><api:text>Published</api:text></api:field><api:field name="title" type="text" display-name="Title"><api:text>Evidence-based medicine: Empiric antibiotic therapy in community-acquired pneumonia</api:text></api:field><api:field name="types" type="list" display-name="Sub types"><api:items><api:item>Review</api:item></api:items></api:field><api:field name="volume" type="text" display-name="Volume"><api:text>39</api:text></api:field></api:native></api:record><api:record format="native" id="848" source-id="2" source-name="pubmed" source-display-name="PubMed" id-at-source="10714789" last-modified-when="2020-04-29T00:33:41.583+01:00"><api:native><api:field name="abstract" type="text" display-name="Abstract"><api:text>A number of national society guidelines exist for empiric management of community-acquired pneumonia but these are, to a large extent, not evidence-based, but based on clinical experience, in vitro data, pragmatism and common sense. Many randomized controlled trials of antibiotic therapy in community-acquired pneumonia have been conducted, but most of these have been powered to demonstrate equivalent efficacy of new treatments in comparison with conventional antimicrobial therapy. Development of new antibiotics has been driven by the emergence of penicillin-resistant Streptococcus pneumoniae, but so far there is no hard evidence that beta-lactam therapy fails in community-acquired pneumonia, at least with the higher doses of penicillins that are commonly used in hospital practice. Nonetheless, newer antibiotics have been deployed including macrolides and quinolones, and have demonstrated equivalent (and in some cases, marginally improved) efficacy to older antibiotic treatments in randomized control trials. A number of studies have shown that it is possible to stratify patients according to severity of illness, to in-patient or out-patient management protocols. These have been validated and refined.</api:text></api:field><api:field name="authors" type="person-list" display-name="Authors"><api:people><api:person><api:links><api:link type="elements/user" id="1878" href="https://mypublications.shef.ac.uk:8091/secure-api/v6.13/users/1878"/></api:links><api:last-name>Read</api:last-name><api:initials>RC</api:initials><api:first-names>RC</api:first-names><api:separate-first-names><api:first-name>R</api:first-name><api:first-name>C</api:first-name></api:separate-first-names><api:addresses><api:address iso-country-code="GB"><api:line type="full">Division of Molecular and Genetic Medicine, University of Sheffield Medical School, UK. R.C.Read@shef.ac.uk</api:line></api:address></api:addresses></api:person></api:people></api:field><api:field name="author-url" type="text" display-name="Link 1"><api:text>https://www.ncbi.nlm.nih.gov/pubmed/10714789</api:text></api:field><api:field name="doi" type="text" display-name="DOI"><api:text>10.1016/s0163-4453(99)90043-9</api:text><api:links><api:link type="doi" href="http://doi.org/10.1016/s0163-4453(99)90043-9"/><api:link type="altmetric" href="http://www.altmetric.com/details.php?doi=10.1016/s0163-4453(99)90043-9"/></api:links></api:field><api:field name="issn" type="text" display-name="ISSN"><api:text>0163-4453</api:text><api:links><api:link type="elements/journal" href="https://mypublications.shef.ac.uk:8091/secure-api/v6.13/journals/974105"/></api:links></api:field><api:field name="issue" type="text" display-name="Issue"><api:text>3</api:text></api:field><api:field name="journal" type="text" display-name="Journal"><api:text>J Infect</api:text></api:field><api:field name="keywords" type="keyword-list" display-name="Keywords"><api:keywords><api:keyword scheme="mesh">Anti-Bacterial Agents</api:keyword><api:keyword scheme="mesh">Community-Acquired Infections</api:keyword><api:keyword scheme="mesh">Humans</api:keyword><api:keyword scheme="mesh">Penicillin Resistance</api:keyword><api:keyword scheme="mesh">Pneumonia, Bacterial</api:keyword><api:keyword scheme="mesh">Practice Guidelines as Topic</api:keyword><api:keyword scheme="mesh">Randomized Controlled Trials as Topic</api:keyword></api:keywords></api:field><api:field name="language" type="text" display-name="Language"><api:text>eng</api:text></api:field><api:field name="location" type="text" display-name="Country"><api:text>England</api:text></api:field><api:field name="pagination" type="pagination" display-name="Pagination"><api:pagination><api:begin-page>171</api:begin-page><api:end-page>178</api:end-page></api:pagination></api:field><api:field name="pii" type="text" display-name="PII"><api:text>S0163-4453(99)90043-9</api:text></api:field><api:field name="publication-date" type="date" display-name="Publication date"><api:date><api:month>11</api:month><api:year>1999</api:year></api:date></api:field><api:field name="publication-status" type="text" display-name="Status"><api:text>Published</api:text></api:field><api:field name="record-made-public-at-source-date" type="date" display-name="Record made publicly available"><api:date><api:day>23</api:day><api:month>3</api:month><api:year>2000</api:year></api:date></api:field><api:field name="title" type="text" display-name="Title"><api:text>Evidence-based medicine: empiric antibiotic therapy in community-acquired pneumonia.</api:text></api:field><api:field name="types" type="list" display-name="Sub types"><api:items><api:item>Journal Article</api:item><api:item>Review</api:item></api:items></api:field><api:field name="volume" type="text" display-name="Volume"><api:text>39</api:text></api:field></api:native></api:record><api:record format="native" id="882093" source-id="18" source-name="epmc" source-display-name="Europe PubMed Central" id-at-source="MED:10714789" last-modified-when="2021-01-19T17:56:58.347+00:00"><api:citation-count>9</api:citation-count><api:native><api:field name="abstract" type="text" display-name="Abstract"><api:text>A number of national society guidelines exist for empiric management of community-acquired pneumonia but these are, to a large extent, not evidence-based, but based on clinical experience, in vitro data, pragmatism and common sense. Many randomized controlled trials of antibiotic therapy in community-acquired pneumonia have been conducted, but most of these have been powered to demonstrate equivalent efficacy of new treatments in comparison with conventional antimicrobial therapy. Development of new antibiotics has been driven by the emergence of penicillin-resistant Streptococcus pneumoniae, but so far there is no hard evidence that beta-lactam therapy fails in community-acquired pneumonia, at least with the higher doses of penicillins that are commonly used in hospital practice. Nonetheless, newer antibiotics have been deployed including macrolides and quinolones, and have demonstrated equivalent (and in some cases, marginally improved) efficacy to older antibiotic treatments in randomized control trials. A number of studies have shown that it is possible to stratify patients according to severity of illness, to in-patient or out-patient management protocols. These have been validated and refined.</api:text></api:field><api:field name="addresses" type="address-list" display-name="Addresses"><api:addresses><api:address iso-country-code="GB"><api:line type="full">Division of Molecular and Genetic Medicine, University of Sheffield Medical School, UK. R.C.Read@shef.ac.uk</api:line></api:address></api:addresses></api:field><api:field name="authors" type="person-list" display-name="Authors"><api:people><api:person><api:links><api:link type="elements/user" id="1878" href="https://mypublications.shef.ac.uk:8091/secure-api/v6.13/users/1878"/></api:links><api:last-name>Read</api:last-name><api:initials>RC</api:initials><api:first-names>RC</api:first-names><api:separate-first-names><api:first-name>R</api:first-name><api:first-name>C</api:first-name></api:separate-first-names><api:identifiers><api:identifier scheme="orcid">0000-0002-4297-6728</api:identifier></api:identifiers></api:person></api:people></api:field><api:field name="doi" type="text" display-name="DOI"><api:text>10.1016/s0163-4453(99)90043-9</api:text><api:links><api:link type="doi" href="http://doi.org/10.1016/s0163-4453(99)90043-9"/><api:link type="altmetric" href="http://www.altmetric.com/details.php?doi=10.1016/s0163-4453(99)90043-9"/></api:links></api:field><api:field name="eissn" type="text" display-name="eISSN"><api:text>1532-2742</api:text><api:links><api:link type="elements/journal" href="https://mypublications.shef.ac.uk:8091/secure-api/v6.13/journals/974105"/></api:links></api:field><api:field name="external-identifiers" type="identifier-list" display-name="External identifiers"><api:identifiers><api:identifier scheme="pubmed">10714789</api:identifier></api:identifiers></api:field><api:field name="is-open-access" type="boolean" display-name="Open access"><api:boolean>false</api:boolean></api:field><api:field name="issn" type="text" display-name="ISSN"><api:text>0163-4453</api:text><api:links><api:link type="elements/journal" href="https://mypublications.shef.ac.uk:8091/secure-api/v6.13/journals/974105"/></api:links></api:field><api:field name="issue" type="text" display-name="Issue"><api:text>3</api:text></api:field><api:field name="journal" type="text" display-name="Journal"><api:text>The Journal of infection</api:text></api:field><api:field name="keywords" type="keyword-list" display-name="Keywords"><api:keywords><api:keyword scheme="mesh">Humans</api:keyword><api:keyword scheme="mesh">Pneumonia, Bacterial</api:keyword><api:keyword scheme="mesh">Community-Acquired Infections</api:keyword><api:keyword scheme="mesh">Anti-Bacterial Agents</api:keyword><api:keyword scheme="mesh">Penicillin Resistance</api:keyword><api:keyword scheme="mesh">Randomized Controlled Trials as Topic</api:keyword><api:keyword scheme="mesh">Practice Guidelines as Topic</api:keyword></api:keywords></api:field><api:field name="language" type="text" display-name="Language"><api:text>eng</api:text></api:field><api:field name="medium" type="text" display-name="Medium"><api:text>Print</api:text></api:field><api:field name="pagination" type="pagination" display-name="Pagination"><api:pagination><api:begin-page>171</api:begin-page><api:end-page>178</api:end-page></api:pagination></api:field><api:field name="publication-date" type="date" display-name="Publication date"><api:date><api:month>11</api:month><api:year>1999</api:year></api:date></api:field><api:field name="publication-status" type="text" display-name="Status"><api:text>Published</api:text></api:field><api:field name="record-created-at-source-date" type="date" display-name="Record created at source"><api:date><api:day>14</api:day><api:month>3</api:month><api:year>2000</api:year></api:date></api:field><api:field name="title" type="text" display-name="Title"><api:text>Evidence-based medicine: empiric antibiotic therapy in community-acquired pneumonia.</api:text></api:field><api:field name="types" type="list" display-name="Sub types"><api:items><api:item>Review</api:item><api:item>Journal Article</api:item></api:items></api:field><api:field name="volume" type="text" display-name="Volume"><api:text>39</api:text></api:field></api:native></api:record><api:record format="native" id="2925873" source-id="10" source-name="dimensions" source-display-name="Dimensions" id-at-source="pub.1044390898" last-modified-when="2024-03-17T09:11:19.397+00:00"><api:citation-count>14</api:citation-count><api:native><api:field name="authors" type="person-list" display-name="Authors"><api:people><api:person><api:links><api:link type="elements/user" id="1878" href="https://mypublications.shef.ac.uk:8091/secure-api/v6.13/users/1878"/></api:links><api:last-name>Read</api:last-name><api:initials>RC</api:initials><api:first-names>Robert C</api:first-names><api:separate-first-names><api:first-name>Robert</api:first-name><api:first-name>C</api:first-name></api:separate-first-names><api:addresses><api:address iso-country-code="GB"><api:line type="organisation">University of Sheffield</api:line><api:line type="city">Sheffield</api:line><api:line type="country">United Kingdom</api:line></api:address></api:addresses><api:identifiers><api:identifier scheme="dimensions-researcher-id">ur.01333750206.10</api:identifier></api:identifiers><api:author-types><api:author-type>corresponding</api:author-type></api:author-types></api:person></api:people></api:field><api:field name="doi" type="text" display-name="DOI"><api:text>10.1016/s0163-4453(99)90043-9</api:text><api:links><api:link type="doi" href="http://doi.org/10.1016/s0163-4453(99)90043-9"/><api:link type="altmetric" href="http://www.altmetric.com/details.php?doi=10.1016/s0163-4453(99)90043-9"/></api:links></api:field><api:field name="external-identifiers" type="identifier-list" display-name="External identifiers"><api:identifiers><api:identifier scheme="pubmed">10714789</api:identifier></api:identifiers></api:field><api:field name="issn" type="text" display-name="ISSN"><api:text>0163-4453</api:text><api:links><api:link type="elements/journal" href="https://mypublications.shef.ac.uk:8091/secure-api/v6.13/journals/974105"/></api:links></api:field><api:field name="issue" type="text" display-name="Issue"><api:text>3</api:text></api:field><api:field name="journal" type="text" display-name="Journal"><api:text>Journal of Infection</api:text></api:field><api:field name="keywords" type="keyword-list" display-name="Keywords"><api:keywords><api:keyword scheme="for-2020">3207 Medical Microbiology</api:keyword><api:keyword scheme="for-2020">32 Biomedical and Clinical Sciences</api:keyword><api:keyword scheme="for-2020">3202 Clinical Sciences</api:keyword><api:keyword scheme="for-2020">3211 Oncology and Carcinogenesis</api:keyword><api:keyword scheme="rcdc">Antimicrobial Resistance</api:keyword><api:keyword scheme="rcdc">Lung</api:keyword><api:keyword scheme="rcdc">Pneumonia</api:keyword><api:keyword scheme="rcdc">Patient Safety</api:keyword><api:keyword scheme="rcdc">Clinical Research</api:keyword><api:keyword scheme="rcdc">Pneumonia &amp; Influenza</api:keyword><api:keyword scheme="rcdc">Infectious Diseases</api:keyword><api:keyword scheme="rcdc">Clinical Trials and Supportive Activities</api:keyword><api:keyword scheme="hrcs-rac">5.1 Pharmaceuticals</api:keyword><api:keyword scheme="hrcs-rac">5 Development of treatments and therapeutic interventions</api:keyword><api:keyword scheme="hrcs-hc">Infection</api:keyword><api:keyword scheme="mesh">Anti-Bacterial Agents</api:keyword><api:keyword scheme="mesh">Community-Acquired Infections</api:keyword><api:keyword scheme="mesh">Humans</api:keyword><api:keyword scheme="mesh">Penicillin Resistance</api:keyword><api:keyword scheme="mesh">Pneumonia, Bacterial</api:keyword><api:keyword scheme="mesh">Practice Guidelines as Topic</api:keyword><api:keyword scheme="mesh">Randomized Controlled Trials as Topic</api:keyword></api:keywords></api:field><api:field name="open-access-status" type="text" display-name="Open access status"><api:text>Closed Access</api:text></api:field><api:field name="pagination" type="pagination" display-name="Pagination"><api:pagination><api:begin-page>171</api:begin-page><api:end-page>178</api:end-page></api:pagination></api:field><api:field name="publication-date" type="date" display-name="Publication date"><api:date><api:month>11</api:month><api:year>1999</api:year></api:date></api:field><api:field name="publisher" type="text" display-name="Publisher"><api:text>Elsevier</api:text></api:field><api:field name="record-created-at-source-date" type="date" display-name="Record created at source"><api:date><api:day>31</api:day><api:month>8</api:month><api:year>2017</api:year></api:date></api:field><api:field name="relative-citation-ratio" type="decimal" display-name="Relative citation ratio"><api:decimal>0.41</api:decimal></api:field><api:field name="title" type="text" display-name="Title"><api:text>Evidence-based medicine: Empiric antibiotic therapy in community-acquired pneumonia</api:text></api:field><api:field name="volume" type="text" display-name="Volume"><api:text>39</api:text></api:field></api:native></api:record><api:record format="native" id="241238" source-id="11" source-name="wos-lite" source-display-name="Web of Science (Lite)" id-at-source="WOS:000085478600001" last-modified-when="2024-03-14T05:41:51.423+00:00"><api:citation-count>14</api:citation-count><api:native><api:field name="authors" type="person-list" display-name="Authors"><api:people><api:person><api:links><api:link type="elements/user" id="1878" href="https://mypublications.shef.ac.uk:8091/secure-api/v6.13/users/1878"/></api:links><api:last-name>Read</api:last-name><api:initials>RC</api:initials><api:first-names>RC</api:first-names><api:separate-first-names><api:first-name>R</api:first-name><api:first-name>C</api:first-name></api:separate-first-names></api:person></api:people></api:field><api:field name="author-url" type="text" display-name="Link 1"><api:text>https://www.webofscience.com/api/gateway?GWVersion=2&amp;SrcApp=sheffield_elements_live&amp;SrcAuth=WosAPI&amp;KeyUT=WOS:000085478600001&amp;DestLinkType=FullRecord&amp;DestApp=WOS_CPL</api:text></api:field><api:field name="doi" type="text" display-name="DOI"><api:text>10.1016/S0163-4453(99)90043-9</api:text><api:links><api:link type="doi" href="http://doi.org/10.1016/S0163-4453(99)90043-9"/><api:link type="altmetric" href="http://www.altmetric.com/details.php?doi=10.1016/S0163-4453(99)90043-9"/></api:links></api:field><api:field name="eissn" type="text" display-name="eISSN"><api:text>1532-2742</api:text><api:links><api:link type="elements/journal" href="https://mypublications.shef.ac.uk:8091/secure-api/v6.13/journals/974105"/></api:links></api:field><api:field name="external-identifiers" type="identifier-list" display-name="External identifiers"><api:identifiers><api:identifier scheme="isidoc">286ZK</api:identifier><api:identifier scheme="pubmed">10714789</api:identifier></api:identifiers></api:field><api:field name="issn" type="text" display-name="ISSN"><api:text>0163-4453</api:text><api:links><api:link type="elements/journal" href="https://mypublications.shef.ac.uk:8091/secure-api/v6.13/journals/974105"/></api:links></api:field><api:field name="issue" type="text" display-name="Issue"><api:text>3</api:text></api:field><api:field name="journal" type="text" display-name="Journal"><api:text>JOURNAL OF INFECTION</api:text></api:field><api:field name="pagination" type="pagination" display-name="Pagination"><api:pagination><api:begin-page>171</api:begin-page><api:end-page>178</api:end-page></api:pagination></api:field><api:field name="publication-date" type="date" display-name="Publication date"><api:date><api:year>1999</api:year></api:date></api:field><api:field name="publication-status" type="text" display-name="Status"><api:text>Published</api:text></api:field><api:field name="title" type="text" display-name="Title"><api:text>Evidence-based medicine: Empiric antibiotic therapy in community-acquired pneumonia</api:text></api:field><api:field name="types" type="list" display-name="Sub types"><api:items><api:item>Review</api:item></api:items></api:field><api:field name="volume" type="text" display-name="Volume"><api:text>39</api:text></api:field></api:native></api:record><api:record format="native" id="24174" source-id="3" source-name="wos" source-display-name="Web of Science" id-at-source="WOS:000085478600001" last-modified-when="2014-07-25T11:06:01.327+01:00"><api:citation-count>9</api:citation-count><api:native><api:field name="authors" type="person-list" display-name="Authors"><api:people><api:person><api:links><api:link type="elements/user" id="1878" href="https://mypublications.shef.ac.uk:8091/secure-api/v6.13/users/1878"/></api:links><api:last-name>Read</api:last-name><api:initials>RC</api:initials><api:first-names>RC</api:first-names><api:separate-first-names><api:first-name>R</api:first-name><api:first-name>C</api:first-name></api:separate-first-names></api:person></api:people></api:field><api:field name="issn" type="text" display-name="ISSN"><api:text>0163-4453</api:text><api:links><api:link type="elements/journal" href="https://mypublications.shef.ac.uk:8091/secure-api/v6.13/journals/974105"/></api:links></api:field><api:field name="issue" type="text" display-name="Issue"><api:text>3</api:text></api:field><api:field name="journal" type="text" display-name="Journal"><api:text>J INFECTION</api:text></api:field><api:field name="keywords" type="keyword-list" display-name="Keywords"><api:keywords><api:keyword>AMOXICILLIN-CLAVULANIC ACID</api:keyword><api:keyword>HOSPITALIZED-PATIENTS</api:keyword><api:keyword>BACTERIAL PNEUMONIA</api:keyword><api:keyword>COMPARATIVE EFFICACY</api:keyword><api:keyword>CEFUROXIME AXETIL</api:keyword><api:keyword>COMPARATIVE TRIAL</api:keyword><api:keyword>DOUBLE-BLIND</api:keyword><api:keyword>ERYTHROMYCIN</api:keyword><api:keyword>CLARITHROMYCIN</api:keyword><api:keyword>SPARFLOXACIN</api:keyword></api:keywords></api:field><api:field name="pagination" type="pagination" display-name="Pagination"><api:pagination><api:begin-page>171</api:begin-page><api:end-page>178</api:end-page></api:pagination></api:field><api:field name="publication-date" type="date" display-name="Publication date"><api:date><api:month>11</api:month><api:year>1999</api:year></api:date></api:field><api:field name="title" type="text" display-name="Title"><api:text>Evidence-based medicine: Empiric antibiotic therapy in community-acquired pneumonia</api:text></api:field><api:field name="volume" type="text" display-name="Volume"><api:text>39</api:text></api:field></api:native></api:record></api:records><api:fields/><api:all-labels type="keyword-list"><api:keywords><api:keyword scheme="mesh" origin="record-data" source="pubmed">Anti-Bacterial Agents</api:keyword><api:keyword scheme="mesh" origin="record-data" source="pubmed">Community-Acquired Infections</api:keyword><api:keyword scheme="mesh" origin="record-data" source="pubmed">Humans</api:keyword><api:keyword scheme="mesh" origin="record-data" source="pubmed">Penicillin Resistance</api:keyword><api:keyword scheme="mesh" origin="record-data" source="pubmed">Pneumonia, Bacterial</api:keyword><api:keyword scheme="mesh" origin="record-data" source="pubmed">Practice Guidelines as Topic</api:keyword><api:keyword scheme="mesh" origin="record-data" source="pubmed">Randomized Controlled Trials as Topic</api:keyword><api:keyword scheme="mesh" origin="record-data" source="epmc">Humans</api:keyword><api:keyword scheme="mesh" origin="record-data" source="epmc">Pneumonia, Bacterial</api:keyword><api:keyword scheme="mesh" origin="record-data" source="epmc">Community-Acquired Infections</api:keyword><api:keyword scheme="mesh" origin="record-data" source="epmc">Anti-Bacterial Agents</api:keyword><api:keyword scheme="mesh" origin="record-data" source="epmc">Penicillin Resistance</api:keyword><api:keyword scheme="mesh" origin="record-data" source="epmc">Randomized Controlled Trials as Topic</api:keyword><api:keyword scheme="mesh" origin="record-data" source="epmc">Practice Guidelines as Topic</api:keyword><api:keyword scheme="for-2020" origin="record-data" source="dimensions">3207 Medical Microbiology</api:keyword><api:keyword scheme="for-2020" origin="record-data" source="dimensions">32 Biomedical and Clinical Sciences</api:keyword><api:keyword scheme="for-2020" origin="record-data" source="dimensions">3202 Clinical Sciences</api:keyword><api:keyword scheme="for-2020" origin="record-data" source="dimensions">3211 Oncology and Carcinogenesis</api:keyword><api:keyword scheme="rcdc" origin="record-data" source="dimensions">Antimicrobial Resistance</api:keyword><api:keyword scheme="rcdc" origin="record-data" source="dimensions">Lung</api:keyword><api:keyword scheme="rcdc" origin="record-data" source="dimensions">Pneumonia</api:keyword><api:keyword scheme="rcdc" origin="record-data" source="dimensions">Patient Safety</api:keyword><api:keyword scheme="rcdc" origin="record-data" source="dimensions">Clinical Research</api:keyword><api:keyword scheme="rcdc" origin="record-data" source="dimensions">Pneumonia &amp; Influenza</api:keyword><api:keyword scheme="rcdc" origin="record-data" source="dimensions">Infectious Diseases</api:keyword><api:keyword scheme="rcdc" origin="record-data" source="dimensions">Clinical Trials and Supportive Activities</api:keyword><api:keyword scheme="hrcs-rac" origin="record-data" source="dimensions">5.1 Pharmaceuticals</api:keyword><api:keyword scheme="hrcs-rac" origin="record-data" source="dimensions">5 Development of treatments and therapeutic interventions</api:keyword><api:keyword scheme="hrcs-hc" origin="record-data" source="dimensions">Infection</api:keyword><api:keyword scheme="mesh" origin="record-data" source="dimensions">Anti-Bacterial Agents</api:keyword><api:keyword scheme="mesh" origin="record-data" source="dimensions">Community-Acquired Infections</api:keyword><api:keyword scheme="mesh" origin="record-data" source="dimensions">Humans</api:keyword><api:keyword scheme="mesh" origin="record-data" source="dimensions">Penicillin Resistance</api:keyword><api:keyword scheme="mesh" origin="record-data" source="dimensions">Pneumonia, Bacterial</api:keyword><api:keyword scheme="mesh" origin="record-data" source="dimensions">Practice Guidelines as Topic</api:keyword><api:keyword scheme="mesh" origin="record-data" source="dimensions">Randomized Controlled Trials as Topic</api:keyword><api:keyword origin="record-data" source="wos">AMOXICILLIN-CLAVULANIC ACID</api:keyword><api:keyword origin="record-data" source="wos">HOSPITALIZED-PATIENTS</api:keyword><api:keyword origin="record-data" source="wos">BACTERIAL PNEUMONIA</api:keyword><api:keyword origin="record-data" source="wos">COMPARATIVE EFFICACY</api:keyword><api:keyword origin="record-data" source="wos">CEFUROXIME AXETIL</api:keyword><api:keyword origin="record-data" source="wos">COMPARATIVE TRIAL</api:keyword><api:keyword origin="record-data" source="wos">DOUBLE-BLIND</api:keyword><api:keyword origin="record-data" source="wos">ERYTHROMYCIN</api:keyword><api:keyword origin="record-data" source="wos">CLARITHROMYCIN</api:keyword><api:keyword origin="record-data" source="wos">SPARFLOXACIN</api:keyword><api:keyword scheme="for" origin="issn-inferred">1103 Clinical Sciences</api:keyword><api:keyword scheme="science-metrix" origin="issn-inferred">Microbiology</api:keyword><api:keyword scheme="for-2020" origin="issn-inferred">3202 Clinical sciences</api:keyword></api:keywords></api:all-labels><api:journal issn="0163-4453" href="https://mypublications.shef.ac.uk:8091/secure-api/v6.13/journals/974105" title="Journal of Infection"><api:records><api:record source-name="summary"><api:title>Journal of Infection</api:title></api:record></api:records></api:journal><api:relationships href="https://mypublications.shef.ac.uk:8091/secure-api/v6.13/publications/848/relationships"/></api:object></api:result></api:response>